An ultrasonic mask according to an embodiment comprises: a first substrate; a first wire disposed on the upper surface of the first substrate; a second substrate disposed above the first substrate; a second wire disposed on the lower surface of the second substrate; a piezoelectric member between the first substrate and the second substrate; a first electrode connected to the first wire and disposed on the lower surface of the piezoelectric member; and a second electrode connected to the second wire and disposed on the upper surface of the piezoelectric member, wherein the first wire and the second wire have curvatures (mm) of 5R to 15R, and the piezoelectric member generates an ultrasonic wave having a frequency band of 20 kHz to 1 MHz.

A wearable phallic lubrication delivery system providing a sheath or framing extending between a closed distal end and an open proximal end for slidably receiving a phallus. An arcuate, circumferential bladder depends from the open proximal end, proximate thereof. A conduit is fluidly coupled to the bladder and extends longitudinally, along the sheath or framing, from adjacent the open proximal end to adjacent the closed distal end. The conduit is connected to but exclusive the sheath or framing. An outlet is provided at the distal end of the conduit, adjacent the tip of the closed proximal end, so that compression of the bladder urges fluid therein through the conduit and out the outlet, thereby simulating ejaculation.

A therapeutic apparatus for treating damaged tissue on a limb or body of a subject includes a wearable adapted to cover and be secured to the limb or body of a subject over damaged tissue. The wearable being configured to reduce pressure on the damaged tissue and adapted to deliver one or more treatments selected from the group consisting of heat, oxygen, electrical current, and light to the damaged tissue.

Wearable system and method for gas delivery to the exterior surface of an eye. In one embodiment, the system may include a gas source and a wearable gas delivery device. The gas source may include a housing, one or more electrochemical gas generating devices positioned within the housing, and a control unit for controlling the operation of the one or more electrochemical gas generating devices. The one or more electrochemical gas generating devices may include an electrochemical oxygen concentrator and a water electrolyzer. Oxygen outputted from the electrochemical oxygen concentrator may be combined with oxygen and/or hydrogen outputted from the electrolyzer to produce a therapeutic gas having an enriched oxygen concentration and a hydrogen concentration less than 4%. The wearable gas delivery device, which is fluidly coupled to the gas source, may be worn over the eye and may be used to deliver the therapeutic gas to the eye.

Provided are devices for therapeutic interaction with an Abreu brain thermal tunnel (ABTT) terminus. Such devices are configured to provide one or more drugs to an ABTT terminus, and may provide heat to or remove heat from the ABTT terminus while providing the one or more drugs.

A light therapy device used for a negative-pressure cup is provided. The light therapy device includes a carrier, a light therapy assembly, a negative ion assembly and a needle protection cap. The carrier is disposed in the negative-pressure cup and includes a panel. The light therapy assembly and the negative ion assembly are disposed in the carrier. The negative ion assembly includes a releasing needle. The releasing needle projects out from the panel to release negative ions. The needle protection cap covers the panel corresponding to the releasing needle to shield the releasing needle. Therefore, the light therapy assembly and the negative ion assembly may be associated with the negative-pressure cup for usage, and the needle protection cap may prevent the user from being stabbed.

A wearable personal protection device for protecting a wearer against airborne pathogens comprises a battery-powered electronic circuit and components for controllable operation of at least one piezoelectric vibrating mesh transducer which is configured to intermittently simultaneously generate and shoot droplets of a biocide fluid into the wearer's proximal airspace to contact and inactivate at least some of the pathogens which may be present; a reservoir for containing the biocide fluid therein; and a fluid delivery apparatus for conveying said biocide fluid to an uptake location of the piezoelectric vibrating mesh transducer.

Methods of applying microcurrent stimulation to a subject may include providing a mask supplying at a minimum moisture to a region to be treated, applying a first electrode connected to a first polarity of microcurrent stimulation circuitry to the mask, applying a second electrode connected to a second polarity of the microcurrent stimulation circuitry to the subject outside of the mask, and providing microcurrent to the first electrode and the second electrode from the microcurrent stimulation circuitry. The method may further include inserting feet of the subject into a liquid having a minimum conductivity of 5 mS/m and vibrating the liquid.

A transdermal delivery system: a delivery device; a band configured to connect the delivery device to a body part of a user, the delivery device comprising: a delivery chamber that is configured to receive a substance and a heating chamber configured to heat the substance in the delivery chamber so that the substance is liquified, vaporized, or both and exits the delivery chamber into contact with the body part of the user so that the substance is transdermally absorbed.

A skin-care product includes a carrier, a middle pad, a protective film. The carrier has an attached surface and an engaging surface opposite to the attached surface. The attached surface is attached to an inner surface of an underwear. The middle pad is disposed on the engaging surface of the carrier and includes a maintenance ingredient for nourishing a human skin and has a contact surface. The protective film is engaged with the middle pad in a way that the protective film entirely covers the contact surface of the middle pad. The attached surface could be detachably connected to or fixed to the inner surface of the underwear. The protective film is removed before using the skin-care product, so that the contact surface of the middle pad could contact the human skin allow the user to do other housework or other activities while performing skincare, enhancing convenience.